MAFG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.970000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.947600E-01
Normal-vs-Stage2
9.213600E-01
Normal-vs-Stage3
8.156000E-01
Normal-vs-Stage4
7.287200E-01
Stage1-vs-Stage2
6.657000E-01
Stage1-vs-Stage3
5.288400E-01
Stage1-vs-Stage4
9.449000E-01
Stage2-vs-Stage3
6.581200E-01
Stage2-vs-Stage4
6.564800E-01
Stage3-vs-Stage4
5.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.089200E-01
Normal-vs-AfricanAmerican
4.115000E-01
Normal-vs-Asian
8.869400E-01
Caucasian-vs-AfricanAmerican
4.731000E-01
Caucasian-vs-Asian
6.073800E-01
AfricanAmerican-vs-Asian
3.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.557000E-01
Normal-vs-Female
8.170800E-01
Male-vs-Female
4.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.672600E-01
Normal-vs-Age(41-60Yrs)
4.275400E-01
Normal-vs-Age(61-80Yrs)
8.732400E-01
Normal-vs-Age(81-100Yrs)
8.388000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.769000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.485600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.351800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.280050E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.525900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.678000E-01
Normal-vs-Daily Drinker
9.130400E-01
Normal-vs-Weekly Drinker
7.360000E-01
Normal-vs-Occasional Drinker
8.157400E-01
Normal-vs-Social Drinker
4.684200E-01
Non Drinker-vs-Daily Drinker
6.692400E-01
Non Drinker-vs-Weekly Drinker
9.381200E-01
Non Drinker-vs-Occasional Drinker
3.070400E-01
Non Drinker-vs-Social Drinker
5.276200E-02
Daily Drinker-vs-Weekly Drinker
7.470000E-01
Daily Drinker-vs-Occasional Drinker
5.370200E-01
Daily Drinker-vs-Social Drinker
1.112590E-01
Weekly Drinker-vs-Occasional Drinker
3.253400E-01
Weekly Drinker-vs-Social Drinker
7.521500E-02
Occasional Drinker-vs-Social Drinker
2.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.365400E-01
Normal-vs-Grade 2
5.908500E-02
Normal-vs-Grade 3
6.460200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.662780E-01
Grade 1-vs-Grade 3
1.597990E-01
Grade 1-vs-Grade 4
2.365400E-01
Grade 2-vs-Grade 3
7.501200E-01
Grade 2-vs-Grade 4
5.908500E-02
Grade 3-vs-Grade 4
6.460200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.925800E-01
Normal-vs-NonDiabetic
8.664000E-01
Diabetic-vs-NonDiabetic
1.720160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.390600E-01
Normal-vs-NoPancreatitis
9.456200E-01
Pancreatitis-vs-NoPancreatitis
1.942090E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.732600E-01
Normal-vs-N1
9.311200E-01
N0-vs-N1
7.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.576000E-01
Normal-vs-TP53-NonMutant
9.326200E-01
TP53-Mutant-vs-TP53-NonMutant
6.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
